Skip to main content
Enter your The Contraceptive Pipeline Database username.
Enter the password that accompanies your username.
LNG butanoate injectable every 3-4 months, dose TBD.
May 30, 2018
Active Pharmaceutical Ingredient (API):
Potential Multi-Purpose Technology (MPT):
Active IND open with the FDA
Potential improvement in safety profile versus DMPA (e.g. bone mineral density) may make this a more appropriate method for adolescents.
May be less amenorrhea than with use of DMPA.
Could be long-acting component of a combined regimen for male hormonal contraception, in combination with a user-controlled androgen preparation (e.g. gel) or other androgen.
Download Product Report